| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/28/2011 | US20110097363 Therapeutically Effective Preparations of Insulin |
| 04/28/2011 | US20110097362 Transmucosal Administration of Aggregated Antigens |
| 04/28/2011 | US20110097306 Oral formulations of cladribine |
| 04/28/2011 | US20110097284 Use and methods for preventing and/or treating oral malodour |
| 04/28/2011 | US20110097283 Chewing gum compositions comprising cannabinoids |
| 04/28/2011 | US20110097282 New Use For Budesonide and Formoterol |
| 04/28/2011 | US20110097281 Foam skin care cream |
| 04/28/2011 | US20110097280 Intracorporeal Medicaments for Photodynamic Treatment of Disease |
| 04/28/2011 | US20110097279 Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses |
| 04/28/2011 | US20110097278 Hair styling compositions and methods of use |
| 04/28/2011 | US20110097277 Particles coated with zwitterionic polymers |
| 04/28/2011 | CA2815437A1 Triptans for the treatment of psoriasis |
| 04/28/2011 | CA2785684A1 Melt-granulated cinacalcet |
| 04/28/2011 | CA2781525A1 Coated capsules and tablets of a fatty acid oil mixture |
| 04/28/2011 | CA2778533A1 Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof |
| 04/28/2011 | CA2778472A1 Compositions and methods for controlling pupil dilation comprising phentolamine |
| 04/28/2011 | CA2778441A1 Methods of making and using compositions comprising flavonoids |
| 04/28/2011 | CA2778411A1 Pharmaceutical composition for oral administration |
| 04/28/2011 | CA2778371A1 A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof |
| 04/28/2011 | CA2778103A1 Donepezil-containing transdermal absorption formulation |
| 04/28/2011 | CA2778009A1 Aqueous patches containing diclofenac sodium |
| 04/28/2011 | CA2777899A1 Composition |
| 04/28/2011 | CA2777794A1 Nested cell encapsulation |
| 04/28/2011 | CA2777489A1 Method for wetting a powder containing benzoyl peroxide |
| 04/28/2011 | CA2777231A1 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with pioglitazone |
| 04/28/2011 | CA2775246A1 Composition comprising solanum glaucophyllum for preventing and/or treating hypocalcaemia and for stabilizing blood calcium levels |
| 04/28/2011 | CA2775110A1 Orally transformable tablets |
| 04/28/2011 | CA2772973A1 Liposomes with improved storage stability |
| 04/28/2011 | CA2765748A1 Pharmaceutical solution of taxanes comprising ph regulator and preparation method thereof |
| 04/27/2011 | EP2314617A2 ActRII receptor polypeptides |
| 04/27/2011 | EP2314608A1 Stabilisation of biosensors for in vivo applications |
| 04/27/2011 | EP2314327A1 Injectable cross-linked polymeric preparations and uses thereof |
| 04/27/2011 | EP2314321A1 Formulations comprising antisense nucleotides to connexins |
| 04/27/2011 | EP2314319A1 Colon Cleansing Compositions |
| 04/27/2011 | EP2314296A1 Orally Disintegrating Tablets of Betahistine |
| 04/27/2011 | EP2314293A1 Implantable device containing resorbable matrix material and rapamycin for preventing or treating vasuloproliferative diseases |
| 04/27/2011 | EP2314288A1 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
| 04/27/2011 | EP2314287A1 Pressure-sensitive adhesive sheet to be stuck to the skin |
| 04/27/2011 | EP2314286A1 Melt granulated cinacalcet |
| 04/27/2011 | EP2314285A1 Lipophilic drug delivery vehicle and methods of us thereof |
| 04/27/2011 | EP2314284A2 Cannabinoid liquid formulations for mucosal administration |
| 04/27/2011 | EP2314283A1 Composition comprising anisic acid and an acid buffer |
| 04/27/2011 | EP2314282A2 Method for transdermal delivery of permeant substances |
| 04/27/2011 | EP2314272A1 Stable hydroalcoholic compositions |
| 04/27/2011 | EP2314171A1 Compositions and process for delivering an additive |
| 04/27/2011 | EP2314154A1 Bolus System |
| 04/27/2011 | EP2313157A2 Cyclosporin derivatives for treating ocular and dermal diseases and conditions |
| 04/27/2011 | EP2313115A2 Polymeric delivery systems for active agents |
| 04/27/2011 | EP2313114A2 A drug powder for inhalation administration and a process thereof |
| 04/27/2011 | EP2313111A1 Toll-like receptor agonist formulations and their use |
| 04/27/2011 | EP2313104A1 Thiolated chitosan gel |
| 04/27/2011 | EP2313103A1 Method of treating blepharitis |
| 04/27/2011 | EP2313101A1 Functional micelles for hard tissue targeted delivery of chemicals |
| 04/27/2011 | EP2313089A2 Electrostatically charged nasal application multipurpose products and method |
| 04/27/2011 | EP2313088A2 Oral pharmaceutical formulation for omeprazole comprising a specific separation layer |
| 04/27/2011 | EP2313087A1 Pharmaceutical dosage form for immediate release of an indolinone derivative |
| 04/27/2011 | EP2313086A2 Controlled release topiramate formulations using intelligent polymers |
| 04/27/2011 | EP2313085A2 Immunogenic amphipathic peptide compositions |
| 04/27/2011 | EP2313084A1 An intrauterine delivery system for contraception |
| 04/27/2011 | EP2313083A1 Oral compositions of clindamycin |
| 04/27/2011 | EP2313054A2 Foaming skincare cream |
| 04/27/2011 | EP2007352B1 Treatment of psychiatric patients with sleep disturbances and/or excessive daytime sleepiness with paliperidone |
| 04/27/2011 | EP1959938B1 Matrix-controlled transdermal system comprising salts of ace inhibitor dicarboxylic acids |
| 04/27/2011 | EP1930436B1 Vector for delivering target substance into nucleus or cell |
| 04/27/2011 | EP1796624B1 Use of a viscoelastic composition for treating increased intraocular pressure |
| 04/27/2011 | EP1792985B1 Cell fusion promoter and utilization of the same |
| 04/27/2011 | EP1578325B1 Stable topical drug delivery compositions |
| 04/27/2011 | EP1404297B1 Reservoir device for intraocular drug delivery |
| 04/27/2011 | EP1317304B1 Slow release pharmaceutical preparation and method of administering same |
| 04/27/2011 | EP1307194B2 Fentanyl composition for nasal administration |
| 04/27/2011 | EP1303541B1 Compositions containing metronidazole |
| 04/27/2011 | CN201806957U Moxa bathing bag |
| 04/27/2011 | CN201806956U Bone joining cataplasm patch |
| 04/27/2011 | CN201806955U Tablet convenient for division |
| 04/27/2011 | CN1960689B Medical plaster for application on the skin |
| 04/27/2011 | CN1919248B Traditional Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease |
| 04/27/2011 | CN1893925B In vivo targeting of dendritic cells |
| 04/27/2011 | CN1872079B Drop pills for treating cardiovascular diseases and cerebrovascular disease, and preparation method |
| 04/27/2011 | CN1861115B Application of Qishen Yiqi dripping pills to prepare medicine for treating acute pancreatitis |
| 04/27/2011 | CN1861114B Application of Qishen Yiqi dripping pills for preparing medicine for preventing and treating high-altitude oxygen deficit |
| 04/27/2011 | CN1861111B Application of dripping pills containing astragalus mongholicus and ginseng for treating senile dementia |
| 04/27/2011 | CN1778336B Preparation of compound Danshen Root dropping ball |
| 04/27/2011 | CN1751705B Traditional Chinese medicine preparation containing red-rooted salvia |
| 04/27/2011 | CN1751704B Traditional Chinese medicine injection containing red-rooted salvia |
| 04/27/2011 | CN1738621B Physically and chemically stable nicotine-containing particulate material |
| 04/27/2011 | CN1639317B Probiotic lactobacillus salivarius strains |
| 04/27/2011 | CN1617708B Taste masked aqueous liquid pharmaceutical composition |
| 04/27/2011 | CN102036686A Water-containing composition |
| 04/27/2011 | CN102036675A Use of black soybean for treating ophthalmic diseases |
| 04/27/2011 | CN102036657A Tablettable chewing gums comprising nicotine and a buffering agent |
| 04/27/2011 | CN102036656A Extended release forumulation containing a wax |
| 04/27/2011 | CN102036655A Process to minimize polymorphism |
| 04/27/2011 | CN102036654A Stabilized atypical antipsychotic formulation |
| 04/27/2011 | CN102036652A Nanostructures suitable for sequestering cholesterol |
| 04/27/2011 | CN102036651A Topical compositions for the controlled delivery of proteins and peptides |
| 04/27/2011 | CN102036572A Emulsions including a PEG-derivative of tocopherol |
| 04/27/2011 | CN102030995A Packed wax composition as Chinese herbal honeyed pill |
| 04/27/2011 | CN102030907A Crosslinked polysiloxanes, a process for their preparation and use of the crosslinked polysiloxanes in emulsifier systems for water-in-oil emulsion |
| 04/27/2011 | CN102030891A TPGS-b-(PLA-ran-PGA) copolymer and preparation method and application thereof |
| 04/27/2011 | CN102028953A Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells |